As per the terms of the agreement, all the companies will jointly organize research and development to evaluate the feasibility of developing various ophthalmic solutions applying Activus Pure Nano-particle Technology (APNT).
The companies said that following the identification of the product, they will sign a separate agreement for the commercialization of the product.